Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.
Mak LY, Gane E, Schwabe C, Yoon KT, Heo J, Scott R, Lee JH, Lee JI, Kweon YO, Weltman M, Harrison SA, Neuschwander-Tetri BA, Cusi K, Loomba R, Given BD, Christianson DR, Garcia-Medel E, Yi M, Hamilton J, Yuen MF. Mak LY, et al. Among authors: yi m. J Hepatol. 2023 Apr;78(4):684-692. doi: 10.1016/j.jhep.2022.11.025. Epub 2022 Dec 10. J Hepatol. 2023. PMID: 36513186 Clinical Trial.
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.
Strnad P, Mandorfer M, Choudhury G, Griffiths W, Trautwein C, Loomba R, Schluep T, Chang T, Yi M, Given BD, Hamilton JC, San Martin J, Teckman JH. Strnad P, et al. Among authors: yi m. N Engl J Med. 2022 Aug 11;387(6):514-524. doi: 10.1056/NEJMoa2205416. Epub 2022 Jun 25. N Engl J Med. 2022. PMID: 35748699 Clinical Trial.
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.
Brugarolas J, Obara G, Beckermann KE, Rini B, Lam ET, Hamilton J, Schluep T, Yi M, Wong S, Mao ZL, Gamelin E, Tannir NM. Brugarolas J, et al. Among authors: yi m. Clin Cancer Res. 2024 Jun 3;30(11):2402-2411. doi: 10.1158/1078-0432.CCR-23-3029. Clin Cancer Res. 2024. PMID: 38652038 Free PMC article. Clinical Trial.
Genome mining of albocandins A-E from Streptomyces sp. YINM00030.
Zhang ZT, Ren Z, Su X, Xie TP, Yi M, Zhou H, Yin M, Ding ZT. Zhang ZT, et al. Among authors: yi m. RSC Adv. 2025 Jan 21;15(3):1805-1812. doi: 10.1039/d4ra08447k. eCollection 2025 Jan 16. RSC Adv. 2025. PMID: 39839228 Free PMC article.
Tailoring traditional Chinese medicine in cancer therapy.
Li S, Chen X, Shi H, Yi M, Xiong B, Li T. Li S, et al. Among authors: yi m. Mol Cancer. 2025 Jan 21;24(1):27. doi: 10.1186/s12943-024-02213-6. Mol Cancer. 2025. PMID: 39838407 Free article. Review.
2,199 results